Global Biosimilars & Follow-on-Biologics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Biosimilars & Follow-on-Biologics Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Biosimilars & Follow-on-Biologics report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biosimilars & Follow-on-Biologics market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Blood Disorders and Oncology Diseases are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biosimilars & Follow-on-Biologics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Biosimilars & Follow-on-Biologics key manufacturers include Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group and Biogen idec, Inc., etc. Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries are top 3 players and held % sales share in total in 2022.
Biosimilars & Follow-on-Biologics can be divided into Human Growth Hormone, Erythropoietin, Monoclonal Antibodies and Insulin, etc. Human Growth Hormone is the mainstream product in the market, accounting for % sales share globally in 2022.
Biosimilars & Follow-on-Biologics is widely used in various fields, such as Blood Disorders, Oncology Diseases, Chronic and Autoimmune Diseases and Growth Hormone Deficiencies, etc. Blood Disorders provides greatest supports to the Biosimilars & Follow-on-Biologics industry development. In 2022, global % sales of Biosimilars & Follow-on-Biologics went into Blood Disorders filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biosimilars & Follow-on-Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

Novartis
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion
Biocon
Hospira
Merck Group
Biogen idec, Inc.
Genentech (Roche Group)
Segment by Type
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biosimilars & Follow-on-Biologics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Biosimilars & Follow-on-Biologics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Biosimilars & Follow-on-Biologics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Biosimilars & Follow-on-Biologics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Biosimilars & Follow-on-Biologics introduction, etc. Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Biosimilars & Follow-on-Biologics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
North America, Europe and Asia Pacific are the key regions for Biosimilars & Follow-on-Biologics industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Biosimilars & Follow-on-Biologics key manufacturers include Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries, LG Life Sciences, Celltrion, Biocon, Hospira, Merck Group and Biogen idec, Inc., etc. Novartis, Synthon Pharmaceuticals, Teva Pharmaceutical Industries are top 3 players and held % sales share in total in 2022.
Biosimilars & Follow-on-Biologics can be divided into Human Growth Hormone, Erythropoietin, Monoclonal Antibodies and Insulin, etc. Human Growth Hormone is the mainstream product in the market, accounting for % sales share globally in 2022.
Biosimilars & Follow-on-Biologics is widely used in various fields, such as Blood Disorders, Oncology Diseases, Chronic and Autoimmune Diseases and Growth Hormone Deficiencies, etc. Blood Disorders provides greatest supports to the Biosimilars & Follow-on-Biologics industry development. In 2022, global % sales of Biosimilars & Follow-on-Biologics went into Blood Disorders filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biosimilars & Follow-on-Biologics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report

By Company
Novartis
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion
Biocon
Hospira
Merck Group
Biogen idec, Inc.
Genentech (Roche Group)
Segment by Type
Human Growth Hormone
Erythropoietin
Monoclonal Antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Peptide
Others
Segment by Application
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biosimilars & Follow-on-Biologics market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Biosimilars & Follow-on-Biologics, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Biosimilars & Follow-on-Biologics industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Biosimilars & Follow-on-Biologics in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Biosimilars & Follow-on-Biologics introduction, etc. Biosimilars & Follow-on-Biologics Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Biosimilars & Follow-on-Biologics market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
